Methotrexate Disodium

• Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting
  2024-518316-39-00 Phase II/III 1 country Medical University Of Lodz
• Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line tr… Recruiting
  2024-512320-11-00 Phase III 2 countries Medical Center - University Of Freiburg
• An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunos… Recruiting
  2023-508251-39-00 Phase III 2 countries Universitaetsklinikum Erlangen AöR
• AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended
  2024-517253-27-00 Phase III 1 country Medical University Of Silesia Katowice Poland
• Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and … Ended
  2024-514473-21-00 Phase III 3 countries Klinikum Der Landeshauptstadt Stuttgart gKAöR
• SPondyloArthritis: inducing drug-free Remission by early TNF-Alpha bloCkade Under guidance of Single cell RNA sequencing and epigenetic prof… Ended
  2023-510085-27-00 Phase III 1 country Universitair Ziekenhuis Gent
• CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended
  2024-513123-17-00 Phase III 1 country Fundacion Para La Investigacion Biomedica Del Hospital Clinico San Carlos
• STRENSIQ® Immunogenicity Study Ended
  2022-502793-17-00 Phase IV 1 country Alexion Pharmaceuticals Inc.
• TOFA-PREDICT Ended
  2024-510903-12-00 Phase IV 1 country Universitair Medisch Centrum Utrecht

Showing 1–9 of 9 trials